As of 2019, around 46 percent of patients with ulcerative colitis worldwide reported discontinuing corticosteriod due to concerns about side effects, compared to around 41 percent of patients with Crohn's disease. This statistic illustrates the percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019.
Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019*
* IBD: Inflammatory Bowel Disease
The survey count represents 523 patients with Crohn's disease, and 319 patients with ulcerative colitis. Respondents were from
the United States (39%), Spain (12%), France
(10%), Germany (10%), the United Kingdom (10%), Italy
(9%), and Canada (9%).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Oxford University Press. (January 29, 2021). Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019* [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/
Oxford University Press. "Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019*." Chart. January 29, 2021. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/
Oxford University Press. (2021). Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019*. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/
Oxford University Press. "Percentage of Ibd Patients Worldwide Reporting Discontinuing Medication Due to Concerns about Side Effects as of 2019*." Statista, Statista Inc., 29 Jan 2021, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/
Oxford University Press, Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019* Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/ (last visited November 10, 2024)
Percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019* [Graph], Oxford University Press, January 29, 2021. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1208544/ibd-patients-discontinuing-medication-due-to-side-effects-concerns-worldwide/
